Literature DB >> 20513775

Antidepressants and pregnancy: complexities of producing evidence-based information.

Adrienne Einarson1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20513775      PMCID： PMC2900322          DOI： 10.1503/cmaj.100507

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  Epidemiology and the medical causes of miscarriage.

Authors:  L Regan; R Rai
Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol       Date:  2000-10

2.  Use of antidepressants during pregnancy and the risk of spontaneous abortion.

Authors:  Hamid Reza Nakhai-Pour; Perrine Broy; Anick Bérard
Journal:  CMAJ       Date:  2010-05-31       Impact factor: 8.262

3.  Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database.

Authors:  Adrienne Einarson; Jacqueline Choi; Thomas R Einarson; Gideon Koren
Journal:  J Obstet Gynaecol Can       Date:  2009-05

4.  GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.

Authors:  Janice Hopkins Tanne
Journal:  BMJ       Date:  2009-10-15

5.  Treatment of miscarriage: current practice and rationale.

Authors:  E Hemminki
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

6.  Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making.

Authors:  L Bonari; G Koren; T R Einarson; J D Jasper; A Taddio; A Einarson
Journal:  Arch Womens Ment Health       Date:  2005-06-17       Impact factor: 3.633

7.  Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

Authors:  Thomas R Einarson; Adrienne Einarson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-12       Impact factor: 2.890

8.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

Review 9.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661
  9 in total
  7 in total

1.  Antidepressant use (during pregnancy) and miscarriage.

Authors:  Anick Bérard; Hamid Reza Nakhai-Pour; Perrine Broy
Journal:  CMAJ       Date:  2010-07-13       Impact factor: 8.262

2.  Antidepressants and pregnancy.

Authors:  Barbara Mintzes; Elia Abi-Jaoude; Anne Rochon Ford
Journal:  CMAJ       Date:  2011-03-22       Impact factor: 8.262

Review 3.  Antenatal depression: a rationale for studying exercise.

Authors:  Geetha Shivakumar; Anna R Brandon; Peter G Snell; Patricia Santiago-Muñoz; Neysa L Johnson; Madhukar H Trivedi; Marlene P Freeman
Journal:  Depress Anxiety       Date:  2010-12-13       Impact factor: 6.505

4.  Maternal Depression and Early Intervention: A Call for an Integration of Services.

Authors:  Shanna L Alvarez; Samantha Meltzer-Brody; Marcia Mandel; Linda Beeber
Journal:  Infants Young Child       Date:  2015 Jan-Mar

Review 5.  Medication management during pregnancy: role of the pharmacist.

Authors:  Nardin Samuel; Adrienne Einarson
Journal:  Int J Clin Pharm       Date:  2011-12

6.  Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.

Authors:  Maiken Ina Siegismund Kjaersgaard; Erik Thorlund Parner; Mogens Vestergaard; Merete Juul Sørensen; Jørn Olsen; Jakob Christensen; Bodil Hammer Bech; Lars Henning Pedersen
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 7.  Optimizing the treatment of mood disorders in the perinatal period.

Authors:  Samantha Meltzer-Brody; Ian Jones
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.